Initial testing of the MDM2 inhibitor RG7112 by the Pediatric Preclinical Testing Program.
Carol H; Reynolds CP; Kang MH; Keir ST; Maris JM; Gorlick R; Kolb EA; Billups CA; Geier B; Kurmasheva RT; Houghton PJ; Smith MA; Lock RB; Pediatric Blood & Cancer, 2013, vol. 60, issue 4, p 633, ISSN 15455017. ISBN 15455017.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef